2026-04-15T23:45:07Zhttps://repository.ucc.edu.co/server/oai/requestoai:repository.ucc.edu.co:20.500.12494/168802024-08-09T17:31:38Zcom_20.500.12494_4col_20.500.12494_23
Trujillo Piso, Dunia Yisela
Gil Palma, Miguel Angel
2020-02-19T20:59:24Z
2020-02-19T20:59:24Z
2020-08-18
2020-02-18
https://hdl.handle.net/20.500.12494/16880
Gil Palma, M. Á. (2020). Biomarcadores moleculares en enfermedad renal aguda para determinar porcentaje de daño en el parenquima: Revisión bibliográfica. (Tesis de pregrado) Recuperado de: http://hdl.handle.net/20.500.12494/16880
La enfermedad renal es una de las patologías mas densas que hay en la clínica diaria de pequeños animales y tiene variedad de etiologías, su diagnóstico es complejo y los mecanismos de tratamiento son diversos dependiendo de los diferentes porcentajes de lesión presente, lo ideal es determinar o aproximar el porcentaje del daño y a su vez poder instaurar el tratamiento idóneo, para así lograr mantener una función renal optima y generar una calidad de vida en los pacientes y por medio de este articulo mostramos los diferentes biomarcadores y su efectividad en la determinación del daño renal y porcentaje afectado en el parénquima.
Kidney disease is one of the densest pathologies that exist in the daily clinic of small animals and has a variety of etiologies, its diagnosis is complex and the treatment mechanisms are diverse depending on the different percentages of lesion present, the ideal is to determine or approximate the percentage of damage and in turn be able to establish the ideal treatment, in order to maintain optimal renal function and generate a quality of life in patients and through this article we show the different biomarkers and their effectiveness in determining renal damage and percentage affected in the parenchyma.
miguel.gilp@campusucc.edu.co
17 p.
Universidad Cooperativa de Colombia, Facultad de Ciencias de la Salud, Medicina Veterinaría y Zootecnia, Ibagué
Medicina veterinaria y zootecnia
Ibagué
Biomarcadores
Enfermedad renal
Caninos
Felinos
Diagnóstico
TG 2020 MVZ 16880
Biomarkers
Kidney disease
Canines
Felines
Diagnosis
Biomarcadores moleculares en enfermedad renal aguda para determinar porcentaje de daño en el parenquima: revisión bibliográfica
Trabajo de grado - Pregrado
http://purl.org/coar/resource_type/c_7a1f
http://purl.org/coar/version/c_ab4af688f83e57aa
info:eu-repo/semantics/bachelorThesis
info:eu-repo/semantics/acceptedVersion
Atribución – No comercial – Compartir igual
info:eu-repo/semantics/closedAccess
http://purl.org/coar/access_right/c_14cb
Chew D, Dibartola S, Schenck P. Canine and feline nephrology and urology. 2nd ed. Louis S, editor. Missouri: Elsevier Inc.; 2011.
Bartges J, Polzin D. Nephrology and urology of small animals. 1st ed. Lowa: Wiley-Blackwell; 2011.
Elliot J, Grauer G. Manual of canine and feline nephrology and urology. 2nd ed. Quedgley: BSAVA; 2007.
IRIS Grading of AKI. International renal interes society. [Online].; 2013 [cited 2019 noviembre 10. Available from: http://www.iris-kidney.com.
Cobrin A. Measurement of serum and urine neutrophil gelatinase-associated lipocalin (NGAL) in dogs with chronic kidney disease, lymphosarcoma, carcinoma and induced endotoxemia to assess diagnostic utility of NGAL in dogs with chronic kidney disease. Tesis presentada de la universidad de guelph como cumplimiento parcial para el grado de doctor en ciencias veterinarias. Ontario:; 2013.
Arias M, Egido J, Lamas S, Praga M, Séron D. Nefrología Clínica. 4th ed. Madrid: Medica Panamericana; 2014.
Almy F. CM, King D. BS. Evaluation of cystatin c as an endogenous marke of glomerular filtration rate in dogs.. Journal of Veterinary Internal Medicine. 2002; 16.
Ross L. Acute kidney injury in dogs and cats. Veterinary Clinics of North America: Small Animal Practice. 2011; 41.
Ostermann M, Philips B, Forni L. Clinical review: biomarkers of acute kidney injury: where are we now. Critical Care. 2012; 16(233).
De Geus H, Betjes M, Bakker J. Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges. Clinical Kidney Journal. 2012; 5.
McDuffie JE, Gao J, Ma J, La D, Bittner A, Sonee M, et al. Novel genomic biomarkers for acute gentamicinnephrotoxicity in dog. Journal of Molecular and Integrative Physiology. 2013; 3.
Bland SK, Cote O, Clark ME, DeLay J, Bienzie D. Characterization of kidney injury molecule-1 in cats. Journal of Veterinary Internal Medicine. 2014; 28.
García MF, Coll E, Ventura S, Bermudo C, Cárdenas MC, Cortés M, et al. Cistatina c en evaluación de la función renal. Revista Laboratorio Clínico. 2011; 4(1).
Ghys L, Paepe D, Smets P, Lefebvre H. DJ, Damiet S. Cystatin c: a new renal marker and its potential use in small animal medicine. Journal of veterinary Internal Medicine. 2014; 28.
Wehner A, Hartmann K, Hirschberger J. Utility of serum cystatin c as a clinical measure of renal function in dogs. J Am Animal Hosp Assoc. 2008; 44(3).
Miyagawa Y, Takemura N, Hirose H. Evaluation of the measurement of serum cystatin c by an enzyme-linked inmmunosorbent assay for humans as a marker of the glomerular filtration rate in dogs. J Vet Med Sci. 2009 septiembre; 71(76).
Cobrin A, Blois SL, Kruth SA, Abrams-Ogg A CG, Dewey C. Biomarker in the assessment of acute and chronic diseases in the dog and cat. Journal of Small Animal Practice. 2013; 54.
Knight E, Verhave J, Spiegelman D, Hillege H. Factors influencing serum cystatin c levels other than renal function and the impact on renal function measurement. Kidney International. 204; 65.
De Loor J, Daminet S, Smets P, Maddens B, Meyer E. Urinary biomarkers for acute kidney injury in dogs. Journal of Veterinary Internal Medicine. 2013; 27.
Nabity MB, Lees GE, Boggess MM, Yerramilli M, Obare E, Yerramili M, et al. Symmetric dimethylarginine assay validation, stability, and evaluation as a marker for the early dteection of chronic kidney disease in dogs. Journal of Veterinary Internal Medicine. 2015; 29(4).
Raila J, Brunnberg L, Schweigert FJ, Kohn B. Influence of kidney function on urinary excretion of albumin and retinolbindig protein in dogs with naturally occurring renal disease. Am J Vet Res. 2010; 71.
Hall JA, Yerramilli M, Obare E, Yerramilli M, Jewell DE. Comparison of serum concentrations of symmetric dimethylarginine and creatinine as kidney function biomarkers in cats with chronic kidney disease. Journal of Veterinary Internal Medicine. 2014; 28.
Hall J, Yerramilli M, Obare E, Yerramilli M, Melendez L, Jewell D. Relationship between lean body mass and serum renal biomarkers in healthy dogs. Journal of Veterinary Internal Medicine. 2015 marzo; 29(3).
Brian J, Obare E, Yerramilli M, Elliott J, Yerramilli M. Relationship between serum symmetric dimethylarginine concentrartion and glomerular filtration rate in cats. Journal of veterinary Internal Medicine. 2014; 28.
Vinge L, Lees GE, Nielsen R, Kashtan CE, Bahr A. The effect of progressive glomerular disease on megalin-mediated endocytosis in kidney. Nephronl Dial Transplant. 2010; 25.
Nabity MB, Lees GE, Cianciolo R, Boggess MM, Steiner JM, Suchodolski JS. Urinary biomarkers of renal disease in dogs with x-linked hereditary nephropathy. J Vet Intern Med. 2012; 26.
Carrillo Esper R, Castillo Albarrán F, Pérez Jáuregui J. Lipocalina asociada con la gelatinasa de neutrófilos, un nuevo marcador de lesión renal aguda en el enfermo grave. Cirugía y Cirujanos. 2011; 79.
Lee YJ, Hu YY, Lin YS, Chang CT, Lin FY, Wong ML, et al. Urine neutrophil gelatinase-associated lipocain (NGAL) as a biomarker for acute canine kidney injury. BMC Veterinary Research. 2012; 8.
Steincbach S, Weis J, Schweighauser A, Francey T, Neiger R. Plasma and urine neutrophil gelatinase-associated lipocalin (NGAL) in dogs with acute kidney injury or chronic kidney. Journal of Veterinary Internal Medicine. 2014; 28.
Seveg G, Palm C, LeRoy B, Cowgill LD, Westropp JL. Evaluation of neutrophil gelatinase-asscoated lipocalin as a marker of kidney injury in dogs. Journal of Veterinary Internal Medicine. 2013; 27.
Bishop SA, Lucke VM, Stoke CR, Gruffydd-Jones TJ. Plasma and urine biochemical changes in cats with experimental inmune complex glomerulonephritis. Journal of Comparative Pathology. 1991; 104.
Jepson RE, Brodbelt D, Vallance C, Syme HM, Elliot J. Evaluation of predictors of the development of azotemia in cats. Journal of Veterinary Internal Medicine. 2009; 23.
Sparkes A, Caney S, Chalhoub S, Elliott J, Finch N, Gajanayake I, et al. ISFM Consensus Guidelines on the Diagnosis and Management of Feline Chronic Kidney Disease. Journal of Feline Medicine and Surgery. 2016; 18.
Di Bartola SP. Renal Disease: Clinical Approach and Laboratory Evaluation. 6th ed. Ettinger SJ FE, editor. Saint Louis: Elsevier Saunders.; 2005.
Watson AD, Lefebvre HP, Concordet D. Plasma exogenous creatinine clearance test in dogs: comparison with other methods and proposed limited sampling strategy. J Vet Inten Med. 2002; 16.
Syme HM. Proteinuria in cats. Pronostic marker or mediator. J Feline Med Surg. 2009; 11.
Lees GE, Jensen WA, Simpson DF. Persistent albuminuria precedes onset of overt proteinuria in male dogs with x-linked hereditary nephropathy. J Vet Intern Med. 2002; 16.
Cotadellas O. Estadificación y Manejo de la enfermedad renal cronica. In Cortadella O, editor. Manual de nefrología y urología clínica canina y felina. Zaragoza: Grupo Asis Biomedia SL; 2012. p. 161-177.
Publicationrestricted